Hepatitis B virus X protein regulates the mEZH2 promoter via the E2F1-binding site in AML12 cells

Chinese Journal of Cancer

Volumn 30, Issue 4, 2011, Pages 273-279

  Shi, Xiao Yan ^a,b   Zhang, Ying Ying ^a   Zhou, Xiao Wei ^a   Lu, Jian Sheng ^a   Guo, Ze Kun ^b   Huang, Pei Tang ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

E2F1; Enhancer of zeste homolog 2 of mouse; Hepatitis B virus; Hepatitis B virus X protein; Promoter activity

Indexed keywords

GENOMIC DNA; HEPATITIS B VIRUS X PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR EZH2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ESCHERICHIA COLI; EXON; GENE; GENE OVEREXPRESSION; GENE SILENCING; HEPATITIS B VIRUS; LIVER CELL; LIVER CELL CARCINOMA; MEZH2 GENE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY SEQUENCE; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 79954549230     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10437     Document Type: Article

References (18)

1. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma [J]. Hepatology, 2008,48 (6):2047-2063.
2. Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors [J]. J Chin Med Assoc, 2007,70(4):141-145.
3. Tang H, Oishi N, Kaneko S, et al. Molecular functions and biological roles of hepatitis B virus x protein [J]. Cancer Sci, 2006,97(10):977-983.
4. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics [J]. Mutat Res, 2008, 647(1-2):21-29.
5. Sasaki M, Ikeda H, Itatsu K, et al. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma [J]. Lab Invest, 2008,88(8):873-882.
6. Yonemitsu Y, Imazeki F, Chiba T, et al. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma [J]. Hum Pathol, 2009,40(9):1304-1311.
7. Sudo T, Utsunomiya T, Mimori K, et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma [J]. Br J Cancer, 2005,92(9):1754-1758.
8. Wang WH, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis [J]. J Biol Chem, 2008,283(37):25455-25467.
9. Matys V, Fricke E, Geffers R, et al. Transfac?: transcriptional regulation, from patterns to profiles [J]. Nucl Acids Res, 2003, 31(1):374-378.
10. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis [J]. World J Gastroenterol, 2007,13(1):74-81.
11. Tonini T, D'Andrilli G, Fucito A, et al. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements [J]. J Cell Physiol, 2008,214(2):295-300.
12. Gong ZB, Li YM, Yu CH, Polycomb group protein EZH2 overexpresses in the hepatocellular carcinoma [J]. J Prac Oncol, 2006,21 (6):523-526. [in Chinese]
13. Laible G, Wolf A, Dorn R, et al. Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres [J]. Embo J, 1997,16(11):3219-3232.
14. O'Carroll D, Erhardt S, Pagani M, et al. The polycomb-group gene Ezh2 is required for early mouse development [J]. Mol Cell Biol, 2001,21(13):4330-4336.
15. Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J]. Embo J, 2003,22(20):5323-5335.
16. Jung JK, Arora P, Pagano JS, et al. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway [J]. Cancer Res, 2007,67(12):5771-5778.
17. Choi BH, Choi M, Jeon HY, et al. Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter [J]. DNA Cell Biol, 2001,20(2):75-80.
18. Choi M, Lee H, Rho HM. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter [J]. IUBMB Life, 2002,53(6):309-317.